Amarin Corp Plc (AMRN)

[ziploc_1]

Many states are currently warning of a shortage of hospital beds, which is expected to get worse in the months ahead...Vascepa can help this crisis by mitigating the symptoms of Covid infections. allowing patients to stay out of hospital...

QUOTE "In addition to biomarker changes(i.e. reduction in CRP in Vascepa treated patients), assessment was made of COVID-19 symptom changes from baseline to 14 days in the influenza patient-reported outcome (FLU-PRO) score, a validated patient-reported outcome measure designed to evaluate the presence, severity and duration of flu symptoms in clinical trials. VASCEPA administration resulted in a significant 52% reduction of the total FLU-PRO prevalence score as compared to a 24% reduction in the usual care group (p=0.003 between groups), with reductions across individual score domains, including a significantly larger reduction compared to usual care in the body/systemic domain (54% vs. 26%; p=0.003). Significant reductions in the FLU-PRO symptom score compared to usual care were also observed in the total symptom score (p=0.003), as well as in the body/systemic (p=0.0007) and chest/respiratory (p=0.01) domains."